M&A Deal Summary

Gryphon Investors Acquires Kano Laboratories

On November 19, 2020, private equity firm Gryphon Investors acquired chemicals company Kano Laboratories

Acquisition Highlights
  • This is Gryphon Investors’ 2nd transaction in the Chemicals sector.
  • This is Gryphon Investors’ 61st transaction in the United States.
  • This is Gryphon Investors’ 3rd transaction in Tennessee.

M&A Deal Summary
Date 2020-11-19
Target Kano Laboratories
Sector Chemicals
Buyer(s) Gryphon Investors
Deal Type Buyout (LBO, MBO, MBI)
Advisor(s) Houlihan Lokey (Financial)
Bass, Berry & Sims (Legal)

Target

Kano Laboratories

Nashville, Tennessee, United States
Kano Laboratories, Inc. is a producer of branded penetrating oils and lubricants in the industrial maintenance, repair, and operations (“MRO”) and consumer markets. Kano Laboratories was founded in 1939 and based in Nashville, Tennessee.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Gryphon Investors

San Francisco, California, United States

Investor Investor Investor Investor Investor

Category Private Equity Firm
Founded 1997
PE ASSETS 8.9B USD
Size Mega
Type Sector Agnostic
DESCRIPTION

Gryphon Investors is a private equity firm focused on making $50 to $300 million of equity or equity-linked investments in middle-market companies. Target transaction situations include traditional buyouts, leveraged build-ups, and growth financings. Gryphon will consider both control and shared-control positions. Sectors of interest include business services, consumer, retail, automotive, chemicals, general manufacturing, healthcare, and hotels. Gryphon Investors was formed in 1997 and is based in San Francisco, California.

DEAL STATS #
Overall 61 of 82
Sector (Chemicals) 2 of 3
Type (Buyout (LBO, MBO, MBI)) 22 of 29
State (Tennessee) 3 of 4
Country (United States) 61 of 81
Year (2020) 6 of 9
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2020-11-16 Vessco

Chanhassen, Minnesota, United States

Vessco, Inc. is a wastewater equipment distributor and value-added service provider in its core territory of the Upper Midwest. Vessco offers its customers an exceptional breadth of products and services with its line card of valued vendors. Vessco provides its products and services in over 18 states. Vessco is based in Chanhassen, Minnesota.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2020-12-01 Matrixx Initiatives

Bridgewater, New Jersey, United States

Matrixx Initiatives, Inc. manufactures and markets Zicam® brand OTC products, including its clinically proven ZICAM® Cold Remedy Nasal Spray and Swab, ZICAM® Cold Remedy RAPIDMELTS®, ZICAM® Cold Remedy Medicated Fruit Drops, ZICAM® Extreme Congestion Relief, and ZICAM® Intense Sinus Relief. Matrixx Initiatives is based in Bridgewater, New Jersey.

Sell -
Mergr

Product

Company

Legal